Retinoblastoma
Original Editor - User Name
Top Contributors - Kapil Narale and Kim Jackson
Introduction[edit | edit source]
Retinoblastoma is the most common ocular cancer that occurs in the pediatric population. It is lethal if it is left untreated. [1]
Epidemiology[edit | edit source]
In high-income countries, retinoblastoma is known to be a curable disease, with close to 100% chance of survival. However, in middle- and low-income countries, the prognosis is extremely low. In addition, more than 80% of cases occur in these countries. [1]
It is estimated that the majority of retinoblastoma cases occur in Asia (53%), then Africa (29%), Latin America (8%), North America (3%), and Europe (6%). With this information it is seen that global retinoblastoma patient survival is <30%. It is seen that the survival rate is 40% (23‑70%) in low‑income countries, while it is 79% (54‑93%) in upper‑middle‑income countries.
Treatment[edit | edit source]
Enucleation has been the preferred mode of treatment, for advanced retinoblastoma, in low-middle-income countries. however, over the last 30 years, the globe-savaging techniques have been used.
Although the management of retinoblastoma may differ from place ot place, and from clinic to clinic, the overall structure of treatment involves a similar framework.
Resources[edit | edit source]
- bulleted list
- x
or
- numbered list
- x
